Share price: 108.00p

AGM STATEMENT

22nd May 2007

At the Annual General Meeting of Cello held today all the resolutions put to shareholders were passed.

In a trading update, Kevin Steeds, Chairman, said:

“Since the announcement of our preliminary results in March, the Group has continued to make good progress.

“Our research and consulting business, which represented approximately 75% of Group profits in 2006, continues to perform well and is gaining clear advantage from its scale. We expect our response business to be more heavily second half weighted than in the past, but given good revenue visibility we are confident about the full year outcome for this business and for the Group as a whole.

In addition we have strengthened our healthcare consulting offer with the addition of The MSI Consultancy and have invested in nqual, an online research company.

“We continue to invest in our existing portfolio of companies to accelerate their organic growth, including several new digital and online initiatives. In addition we are appraising a small number of exciting new opportunities in all areas of our operations that will further develop our capabilities and add shareholder value.”

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150